Teva Pharmaceutical Industries Ltd. - Company & Market Research Reports

Home /
Companies /
Teva Pharmaceutical Industries Ltd.

Teva Pharmaceuticals develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. The company has a portfolio of more than 1,000 molecules, producing approximately 64 billion tablets and capsules a year at 66 manufacturing facilities. It currently ranks among the 10 top pharmaceutical companies in the world and is active in 60 countries. Founded in 1901, and based in Israel, Teva employs approximately 58,000 people around the world.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 314
Cardiovascular Drugs 205
Infectious Diseases Drugs 199
Oncology Drugs 174
Respiratory Drugs 168
Immune Disorders Drugs 166
Analgesics 166
Musculoskeletal Disorders Drugs 155
Gastrointestinal Drugs 145
Endocrine and Metabolic Disorders Drugs 138
Infusions and Injectables 134
Sexual and Reproductive Health Drugs 132
Generic Drugs 112
Antibiotics 103
Over the Counter (OTC) Drugs 97
Pharmaceuticals 95
Drug Delivery 73
Urological Disorders Drugs 69
Inhalers and Nebulisers 65
Pharmaceutical Intermediates 63
Biopharmaceuticals 61
Mental Disorders Drugs 59
Dermatological Drugs 58
Animal Pharmaceuticals 56
Biosimilars and Biosuperiors 56
Transdermal and Transmucosal Drug Delivery 54
Hematological Drugs 52
Liver and Kidney Disorders Drugs 51
Asthma Drugs 50
Leukemia Drugs 49
Optical Disorders Drugs 48
Lung Cancer Drugs 48
Breast Cancer Drugs 45
Clinical Trials 38
Allergy Drugs 36
Immunosuppressive Drugs 34
Addiction Disorders Drugs 33
Drug Discovery 33
Anxiety Drugs 31
Anesthetic Drugs 30
Diabetes Drugs 29
Ovarian Cancer Drugs 28
Bronchitis Drugs 28
Pancreatic Cancer Drugs 27
Acne Drugs 27
Cough and Cold Drugs 26
Psoriasis Drugs 26
Drugs by Therapeutic Area 25
HIV/AIDS Drugs 25
Pharmaceutical Manufacturing 25
Brain Cancer Drugs 24
Prostate Cancer Drugs 23
Lymphoma Drugs 23
Vitamins and Dietary Supplements 23
Alzheimer's Disease Drugs 22
Skin Cancer Drugs 21
Thyroid Cancer Drugs 21
Schizophrenia Drugs 19
Colon Cancer Drugs 18
Bladder Cancer Drugs 16
Liver Cancer Drugs 15
Kidney Cancer Drugs 14
Cervical Cancer Drugs 11
Anti-Obesity Drugs 9
Vaccines 8
Company Reports 4
Uterine Cancer Drugs 4
Pharmacoeconomics 1
Cancer Vaccines 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



287 reviews

3,039 Results (Page 9 of 152)
- Relevance
  Sort by

Budesonide Inhaler Market - Global Forecast 2026-2032

 Report
September 2026
197 Pages
Global

From

€3299EUR$3,545USD£2,759GBP

€3666EUR$3,939USD£3,066GBP

Cytotoxic Drugs & HPAPI Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of Highly Potent Finished Dosage Form and Key Geographies

 Report
October 2025
442 Pages
Global

From

€4466EUR$4,799USD£3,735GBP

Generic Oncology Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
116 Pages
Global

From

€4188EUR$4,500USD£3,503GBP

Generic Injectables Market - Global Forecast 2026-2032

 Report
September 2026
188 Pages
Global

From

€3299EUR$3,545USD£2,759GBP

€3666EUR$3,939USD£3,066GBP

Edoxaban Tosilate Tablets & Generic Drugs Market - Global Forecast 2025-2030

 Report
August 2025
197 Pages
Global

From

€3299EUR$3,545USD£2,759GBP

€3666EUR$3,939USD£3,066GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Generic Musculoskeletal Disorders Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4179EUR$4,490USD£3,495GBP

Ziprasidone Mesylate for Injection Market - Global Forecast 2026-2032

 Report
September 2026
183 Pages
Global

From

€3299EUR$3,545USD£2,759GBP

€3666EUR$3,939USD£3,066GBP

Risperidone Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
126 Pages
Global

From

€3500EUR$4,028USD£3,030GBP

Progressive Multifocal Leukoencephalopathy Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4179EUR$4,490USD£3,495GBP

Quetiapine Fumarate Tablets Market - Global Forecast 2026-2032

 Report
September 2026
195 Pages
Global

From

€3299EUR$3,545USD£2,759GBP

€3666EUR$3,939USD£3,066GBP

Low Molecular Weight Heparin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Enoxaparin, Dalteparin, Tinzaparin, Fraxiparine, Nadroparin, and Others), Packaging (Multi-Vials and Prefilled Syringes), Application , and End User, and Geography

 Report
December 2021
191 Pages
Global

From

€4142EUR$4,450USD£3,464GBP

Nitrofurantoin Macrocrystals Capsules Market - Global Forecast 2026-2032

 Report
September 2026
194 Pages
Global

From

€3299EUR$3,545USD£2,759GBP

€3666EUR$3,939USD£3,066GBP

Ertapenem Sodium API Market - Global Forecast 2026-2032

 Report
September 2026
183 Pages
Global

From

€3299EUR$3,545USD£2,759GBP

€3666EUR$3,939USD£3,066GBP

Buccal Drug Delivery Systems Market - Global Forecast 2026-2032

 Report
September 2026
181 Pages
Global

From

€3299EUR$3,545USD£2,759GBP

€3666EUR$3,939USD£3,066GBP

Generic Oncology Sterile Injectable Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4179EUR$4,490USD£3,495GBP

Nebulizer Inhalation Medication for Children Market - Global Forecast 2026-2032

 Report
September 2026
180 Pages
Global

From

€3299EUR$3,545USD£2,759GBP

€3666EUR$3,939USD£3,066GBP

Paclitaxel Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
102 Pages
Global

From

€3500EUR$4,028USD£3,030GBP

Pioglitazone Hydrochloride Tablets Market - Global Forecast 2025-2030

 Report
August 2025
197 Pages
Global

From

€3299EUR$3,545USD£2,759GBP

€3666EUR$3,939USD£3,066GBP

Generic Injectables Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4179EUR$4,490USD£3,495GBP

Generic Central Nervous System Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4179EUR$4,490USD£3,495GBP

3,039 Results (Page 9 of 152)
- 1
- 7
- 8
- 9
- 10
- 11

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.